Back
Top 1%
15.2%
Top 0.8%
9.4%
#1
8.1%
Top 15%
6.7%
Top 0.5%
6.7%
Top 70%
6.7%
Top 41%
6.2%
Top 0.5%
4.3%
Top 2%
2.9%
Top 0.5%
2.0%
Top 20%
2.0%
Top 2%
2.0%
Top 5%
1.6%
Top 0.5%
1.4%
Top 3%
1.4%
Top 0.4%
1.2%
Top 19%
1.2%
Top 8%
1.2%
Top 4%
1.0%
Top 7%
1.0%
Top 15%
1.0%
Top 2%
0.7%
Top 13%
0.7%
Top 6%
0.7%
Top 4%
0.7%
ROR1 is a novel putative druggable target for diffuse glioma
2021-12-05
oncology
Title + abstract only
View on medRxiv
Show abstract
The cell surface receptor ROR1 is a therapeutic target of growing interest in oncology; however, its role in glioma has not been established thus far. This study analyzed associations between ROR1 mRNA expression and clinical outcomes, and histological and molecular subtypes in four independent glioma (grades II-IV) transcriptomic datasets (The Cancer Genome Atlas-GBMLGG, Chinese Glioma Genome Atlas, Repository for Molecular Brain Neoplasia, and GSE16011), encompassing a total of 2,388 cases. Th...
Predicted journal destinations
1
Cancers
57 training papers
2
Frontiers in Oncology
34 training papers
3
Aging
18 training papers
4
Nature Communications
483 training papers
5
Clinical Cancer Research
22 training papers
6
PLOS ONE
1737 training papers
7
Scientific Reports
701 training papers
8
Cancer Medicine
17 training papers
9
British Journal of Cancer
22 training papers
10
PeerJ
46 training papers
11
eLife
262 training papers
12
BMC Cancer
21 training papers
13
Computers in Biology and Medicine
39 training papers
14
Clinical Epigenetics
21 training papers
15
Frontiers in Neuroscience
29 training papers
16
EBioMedicine
21 training papers
17
JAMA Network Open
125 training papers
18
iScience
74 training papers
19
International Journal of Molecular Sciences
39 training papers
20
The American Journal of Human Genetics
77 training papers
21
Proceedings of the National Academy of Sciences
100 training papers
22
Cell Reports
25 training papers
23
Frontiers in Immunology
140 training papers
24
Diagnostics
36 training papers
25
Communications Biology
36 training papers